---
title: "ALLR.US (ALLR.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ALLR.US/news.md"
symbol: "ALLR.US"
name: "ALLR.US"
parent: "https://longbridge.com/en/quote/ALLR.US.md"
datetime: "2026-03-09T15:33:27.510Z"
locales:
  - [en](https://longbridge.com/en/quote/ALLR.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALLR.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALLR.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ALLR.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ALLR.US/news.md)


# ALLR.US (ALLR.US) — Related News

### [Allarity Secures $20 Million To Propel Stenoparib Toward FDA Approval; Stock Up](https://longbridge.com/en/news/278341007.md)
*2026-03-09T06:45:30.000Z*
> Allarity Therapeutics, Inc. has secured $20 million in non-convertible debt financing from Streeterville Capital to adva

### [Allarity Therapeutics Secures $20 Million Structured Note Financing](https://longbridge.com/en/news/278112722.md)
*2026-03-06T13:47:51.000Z*
> Allarity Therapeutics has secured $20 million in structured note financing through a note purchase agreement with Street

### [REG - AIM - AIM Notice - 26/02/2026](https://longbridge.com/en/news/277002244.md)
*2026-02-26T08:00:00.000Z*
> The London Stock Exchange has admitted the following securities to trading on AIM as of February 26, 2026: Allergy Thera

### [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://longbridge.com/en/news/276441716.md)
*2026-02-20T12:05:47.000Z*
> In Friday's pre-market session, Cardio Diagnostics Holdings (CDIO) led gainers with a 19.6% increase to $2.68, followed 

### [US Stock Movement Update: Abits surged 163.29%, Rackspace Tech rose 64.49%, Twin Vee PowerCats fell 54.59%](https://longbridge.com/en/news/276477237.md)
*2026-02-20T19:00:19.000Z*
> Overview of the US Stock Market: The current market shows a clear divergence between strengths and weaknesses, with tech

### [](https://longbridge.com/en/news/276267273.md)
*2026-02-18T19:46:02.000Z*
> Allarity Therapeutics shares are trading higher. The company announced that the first patients have been dosed with sten

### [Viatris ernennt Matthew J. Maletta zum neuen Chief Legal Officer](https://longbridge.com/en/news/274665044.md)
*2026-02-03T13:30:56.000Z*
> Viatris Inc. has announced the appointment of Matthew J. Maletta as the new Chief Legal Officer, effective February 9, 2

### [Allarity Therapeutics Partners with U.S. Department of Veterans Affairs for Phase 2 Cancer Trial](https://longbridge.com/en/news/274659689.md)
*2026-02-03T13:00:30.000Z*
> Allarity Therapeutics Inc. has partnered with the U.S. Department of Veterans Affairs to conduct a Phase 2 clinical tria